Pfizer (PFE)

EBITDA Margin

21.18%

TTM · Period ending:

PFE logo

PFE EBITDA Margin

Latest reported21.18%
PFE TTM EBITDA Margin (25.50% → 21.18%)
High-resolution chart · PNG

PFE ebitda margin history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Pfizer EBITDA Margin — Trailing twelve months (TTM)
Period endingEBITDA Margin
21.1803%
27.131%
26.8189%
33.7182%
35.679%
31.79%
32.6104%
22.8944%
9.7576%
13.284%
16.0527%
26.5525%
38.2372%
41.3811%
40.8976%
39.4347%
37.9172%
36.8472%
37.81%
39.4621%
35.9234%
34.3393%
31.1959%
26.5753%
48.485%
48.1084%
48.8251%
49.0988%
36.255%
36.7819%
36.5078%
40.0502%
38.9629%
38.029%
37.7631%
37.3737%
33.2989%
30.0753%
28.9546%
26.4387%
28.7515%
31.3029%
31.3627%
36.3153%
38.2023%
39.0178%
38.5788%
41.2629%
41.3853%
44.3268%
44.8855%
42.5974%
40.5101%
37.1174%
34.5444%
34.612%
34.9575%
33.7987%
34.1891%
32.8986%
30.2612%
30.6908%
30.6405%
26.8473%
30.801%
30.8219%
33.7339%
44.7466%
43.7752%
42.3671%
41.345%
37.7263%
31.9491%
30.9801%
32.0872%
32.6224%
38.6119%
40.5882%
39.7188%
41.3395%
40.8605%
39.9178%
39.331%
40.1117%
41.07%
39.2421%
39.7201%
37.4763%
33.8181%
33.7335%
32.7388%
36.1008%
38.9878%
41.0758%
39.8523%
36.289%
36.511%
37.3123%
37.3353%
36.8374%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.